Systematic glaucoma screening and diagnostic effectiveness: improving patient outcomes through early detection

系统性青光眼筛查和诊断有效性：通过早期检测改善患者预后

• 批准号: nhmrc : 1033224
• 负责人: A/Pr Paul Healey
• 金额: $ 76.96万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Partnerships
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/systematic-glaucoma-screening-early-detection/110887
• 关键词: Systematic; glaucoma; screening; diagnostic; effectiveness

The provision of eyecare in Australia has significantly changed over the past decade. Major challenges have been created because of our ageing population with chronic ocular diseases (eg, glaucoma), expanded scope of practice including co-management options for glaucoma and dramatic expansion of technology associated with glaucoma diagnosis. Major questions have therefore arisen in relation to policy issues, service delivery and how research results are integrated with the overall aim being for the early diagnosis of glaucoma.

在过去的十年里，澳大利亚的眼科护理服务发生了重大变化。由于我们的慢性眼部疾病（如青光眼）人口老龄化，实践范围扩大，包括青光眼的共同管理选项以及青光眼诊断相关技术的急剧扩展，因此产生了重大挑战。因此，在政策问题、服务提供以及如何将研究结果与青光眼早期诊断的总体目标相结合方面出现了重大问题。